Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT06699407
PHASE4

Qishenyiqi for Ventricular Remodeling After Myocardial Infarction

Sponsor: Qilu Hospital of Shandong University

View on ClinicalTrials.gov

Summary

The effects of Qishenyiqi dripping pill on cardiac remodeling in patients with chronic stable heart failure have not been reported. This project aims to clarify the efficacy and safety of Qishenyiqi in patients with chronic heart failure after myocardial infarction. Patients with chronic stable heart failure after myocardial infarction were selected and randomly divided into two groups: the treatment group was treated with Qishenyiqi dripping pills; The control group was given placebo treatment. After 12 months of follow-up, the effects of Qishenyiqi on cardiac remodeling and function and cardiovascular adverse events were evaluated. The results are helpful to provide a new treatment strategy for chronic heart failure.

Official title: Efficacy and Safety of Qishenyiqi Dripping Pills in Patients With Ventricular Remodeling and Chronic Heart Failure With Reduced Ejection Fraction After Myocardial Infarction

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

210

Start Date

2024-11-20

Completion Date

2027-12-31

Last Updated

2024-11-21

Healthy Volunteers

No

Interventions

DRUG

Qishenyiqi dripping pills

Qishenyiqi dripping pills, 1 bag once, three times a day, 12 months

DRUG

Placebo

Placebo, 1 bag once, three times a day, 12 months

Locations (3)

Panpan Hao

Jinan, Shandong, China

Qianfoshan Hospital, Shandong University

Jinan, Shandong, China

Jinan Central Hospital Affiliated to Shandong First Medical University

Jinan, China